
A phase I study of zzso zzso was performed in 40 children with advanced zzso A single course of zzso consisted of 4 weekly zzso infusions followed by a zzso zzso The starting dose of 100 zzso was zzso of the maximum tolerated dose in zzso zzso dose levels given were: zzso zzso zzso and 210 zzso zzso was dose limiting, with zzso more pronounced than zzso There was no evidence of cumulative zzso The maximum tolerated dose for children with solid tumors was 210 zzso X zzso Other side effects included transient zzso and vomiting at the higher dose levels and zzso zzso changes in zzso zzso One patient developed zzso No zzso toxicity was zzso Among the 28 zzso patients with solid tumors, one of ten with zzso zzso had complete disappearance of a lung zzso for zzso zzso Two of four patients with zzso had partial responses by clinical and computerized zzso scan for 4 and 10 zzso All three zzso had received prior zzso zzso zzso has major advantages over zzso in terms of reduced zzso zzso observed in patients previously treated with zzso are zzso The recommended phase II dose for children with solid tumors is 175 zzso X 4 with a zzso zzso 

